Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

...

...

...

...

...

...

...

...

...

...

...

The following is a brief description of the relevant columns in the folder view below (by column header):


https://www.synapse.org/#!Synapse:syn18488466/tables/

NOTE: Studies are selected in this view with is.study == TRUE 

The legacy table upon which the above project view was created is: https://www.synapse.org/#!Synapse:syn10915872/tables/

data portal name: name as it should appear in data portal

synapse file view column: corresponding name (e.g., for SQL query) in Synapse table view

card location: primary (i.e., top) or secondary (i.e., bottom) key/annotation

facet: true if column_name should be faceted in data portal.


File view driving this table: https://www.synapse.org/#!Synapse:syn9630847/tables/

...

facet: true if column_name should be faceted in data portal.

card location: primary (i.e., top) or secondary (i.e., bottom) key/annotation

The following annotations do not exist on file: 

...

column namecurrent synapse file view columneventual synapse file view columnfacetcard locationconceptexampleGDC equivalentfaceted on GDCfacet on CSBCGDC referencesizerestricted valuescommentsin AMP-AD portalin NF portal
Grant Type

yesNA
U54 or U01








Grant

yesNA










Program

yesNA
CSBC or PSON








Speciesspeciesspeciesyessecondary

none
yes





Scientific ThemeNAthemeyessecondary (or possibly pill directly beneath file name)
tumor-heterogeneitynone
yes





Number of Samples

nosecondary










Data Categoryassaydata_categoryyessecondaryBroad categorization of the contents of the data file.
  • Transcriptome Profiling
data_categoryyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)

Experiment Strategyassayexperimental_strategyyessecondaryThe sequencing strategy used to generate the data file.  REMOVE "sequencing" for CSBC.
  • RNA-Seq
  • Total RNA-Seq
experimental_strategyyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)

Platform

yesNA

platformyesyes





Disease Type

yessecondaryThe text term used to describe the type of malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Acinar Cell Neoplasms
  • Adenomas and Adenocarcinomas
  • Adnexal and Skin Appendage Neoplasms
  • Basal Cell Neoplasms
  • Blood Vessel Tumors
case/disease_typeyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=case




Site

yessecondaryThe text term used to describe the general location of the malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Accessory sinuses
  • Adrenal gland
  • Anus and anal canal
  • Base of tongue
  • Bladder
case/primary_siteyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=case




Tissue

yessecondaryThe text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Abdomen, NOS
  • Abdominal esophagus
  • Accessory sinus, NOS
  • Acoustic nerve
  • Adrenal gland, NOS
diagnosis/tissue_or_organ_of_originyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




...